Literature DB >> 2226990

Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy.

G R Snibson1, J L Greaves, N D Soper, J I Prydal, C G Wilson, A J Bron.   

Abstract

Sodium hyaluronate solutions have been advocated in the management of a variety of dry-eye states. By virtue of their non-Newtonian rheological properties, formulations exhibiting high zero-shear viscosities may be used as an artificial tear with the expectation of prolonged precorneal residence times and improved tolerance. Quantitative gamma scintigraphy was used to evaluate the residence times of 0.2% and 0.3% sodium hyaluronate solutions and a polymer-free solution of buffered saline in 12 patients with keratoconjunctivitis sicca and a group of six normal volunteers. Using several indices of residence time, mean values for the sodium hyaluronate solutions were significantly longer than those for buffered saline. Parallel changes in tear film thickness were also demonstrated using a technique based on laser interferometry.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226990     DOI: 10.1038/eye.1990.83

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  17 in total

Review 1.  Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

Authors:  A C Perkins; M Frier
Journal:  Pharm World Sci       Date:  1996-06

2.  The effect of pH, dilution, and temperature on the viscosity of ocular lubricants--shift in rheological parameters and potential clinical significance.

Authors:  M Q Rahman; K-S Chuah; E C A Macdonald; J P M Trusler; K Ramaesh
Journal:  Eye (Lond)       Date:  2012-10-19       Impact factor: 3.775

3.  Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients.

Authors:  P Aragona; G Di Stefano; F Ferreri; R Spinella; A Stilo
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

4.  Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin.

Authors:  S F Bernatchez; C Tabatabay; R Gurny
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-03       Impact factor: 3.117

5.  Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro.

Authors:  J A P Gomes; R Amankwah; A Powell-Richards; H S Dua
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

6.  Ocular contact time of a carbomer gel (GelTears) in humans.

Authors:  C G Wilson; Y P Zhu; M Frier; L S Rao; P Gilchrist; A C Perkins
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

Review 7.  Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye.

Authors:  Diane D-S Tang-Liu; Andrew Acheampong
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

8.  Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.

Authors:  Yuri S Astakhov; Sergei Y Astakhov; Alla B Lisochkina
Journal:  Clin Ophthalmol       Date:  2013-12-09

9.  Increased concentration of hyaluronan in tears after soaking contact lenses in Biotrue multipurpose solution.

Authors:  Catherine A Scheuer; Marjorie J Rah; William T Reindel
Journal:  Clin Ophthalmol       Date:  2016-10-07

10.  The Effect of Tear Supplementation on Ocular Surface Sensations during the Interblink Interval in Patients with Dry Eye.

Authors:  Lóránt Dienes; Huba J Kiss; Kristóf Perényi; Zsuzsanna Szepessy; Zoltán Z Nagy; Árpád Barsi; M Carmen Acosta; Juana Gallar; Illés Kovács
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.